HOME >> MEDICINE >> NEWS
Study shows use of budesonide reduced the risk of asthma related events by 40% in children

San Antonio, Tex., - March 19, 2005 New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.

The findings, presented today at the 61st annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), are from two analyses of the Inhaled Steroid as Regular Therapy in Early Asthma (START) study, a three-year trial involving nearly 2,000 children aged 5 to 10 years with mild persistent asthma. The START study was funded by AstraZeneca.

"Many children with asthma make repeated trips to the emergency room or are hospitalized because of worsening symptoms," said Dr. Albert Sheffer, Clinical Professor of Medicine at Harvard Medical School, Director Emeritus at the Allergy Clinic, Brigham and Women's Hospital in Boston and an investigator in the safety and tolerability portion of the study. "The findings of these two analyses showed that budesonide had a viable long-term treatment effect."

In the first analysis, 1,974 children were randomized to receive either once-daily budesonide or placebo in addition to usual asthma care. The earlier use of budesonide reduced the risk of exacerbation, or severe asthma related events by 40 percent compared to usual asthma care. In addition, children in the budesonide group required fewer interventions with other inhaled corticosteroids (12.3 percent versus 22.7 percent for placebo), and had improved lung function.

The second analysis tracked the adverse side effects reported by 1,981 children taking either budesonide plus usual care or placebo over three years. Overall, the incidence of side effects was comparable between the two groups, with fewer asthma exacerbations and adverse events reported in the budesonide group throughout
'"/>

Contact: Heather Law
heather.law@astrazeneca.com
302-886-1652
Burson-Marsteller
21-Mar-2005


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... Colo. (PRWEB) , ... August 14, 2019 , ... Inc. ... #2008 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... #41 among Colorado based companies and #153 in the Health sector. The list represents ...
(Date:8/14/2019)... PASADENA, Calif. (PRWEB) , ... August 13, 2019 ... ... Pasadena, California has joined the esteemed Haute Beauty network. , The Haute Beauty ... privileged to present Dr. Reyes-Bergano as a leading aesthetic medicine expert and our ...
(Date:8/14/2019)... ... August 14, 2019 , ... Today, consumers are taking a harder look ... their physical body, emotions and energy levels. The trick is finding food and beverages ... , That’s why founder Chris Harper created Chase – a delicious, guilt ...
(Date:8/12/2019)... ... August 12, 2019 , ... ... the $56,595,000 Series 2019A&B Bonds for Lesley University, which is currently rated A-/Stable ... 2019 Bonds will be used primarily to refund the outstanding debt on the ...
(Date:8/9/2019)... , ... August 09, 2019 , ... ... the continuation of its global expansion into Europe’s third largest pharmaceutical market with ... , Advanced Clinical’s entrance into Italy now completes the organization’s thorough coverage of ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... ... GA, 30501, is a comprehensive family dental practice that serves the Gainesville community ... cosmetic dentistry , endodontics and restorative dental care. The well-established practice is ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... 2005, announced it has successfully completed enrollment of 690 patients for a phase ... dose ranging, multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of ...
(Date:8/15/2019)... ... August 15, 2019 , ... Donor ... for intended parents who are looking for egg donors, gestational surrogates and sperm ... looking for the ultimate concierge service and hands-on help in creating their families ...
Breaking Medicine Technology:
Cached News: